Unkind cytokines: Current evidence for the potential role of cytokines in immune-mediated depression

International Review of Psychiatry

Volumn 17, Issue 6, 2005, Pages 477-483

  Pucak, Michele L ^a   Kaplin, Adam I ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIDEPRESSANT AGENT; CORTICOSTERONE; CORTICOTROPIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; KYNURENINE; QUINOLINIC ACID; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; TUMOR NECROSIS FACTOR ALPHA;

AMYOTROPHIC LATERAL SCLEROSIS; ANHEDONIA; ANOREXIA; APPETITE DISORDER; ASTHENIA; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DEPRESSION; DISEASE SEVERITY; FATIGUE; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; ILLNESS BEHAVIOR; IMMUNE FUNCTION TEST; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNE SYSTEM; INSOMNIA; IRRITABILITY; MEMORY DISORDER; MENTAL DISEASE; MONOAMINERGIC SYSTEM; MULTIPLE SCLEROSIS; NERVOUS SYSTEM; NERVOUS SYSTEM DEVELOPMENT; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; REVIEW; SIDE EFFECT; STRESS; SUICIDAL BEHAVIOR;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; CYTOKINES; DEPRESSIVE DISORDER; HIPPOCAMPUS; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LIPOPOLYSACCHARIDES; PSYCHONEUROIMMUNOLOGY; SEROTONIN; STRESS, PSYCHOLOGICAL; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30644478019     PISSN: 09540261     EISSN: None     Source Type: Journal    
DOI: 10.1080/02646830500381757     Document Type: Review

References (55)

1. Anisman, H., Kokkinidis, L., Borowski, T., & Merali, Z. (1998). Differential effects of interleukin (IL)-1beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Research, 779(1-2), 177-187.
2. Anisman, H., Merali, Z., Poulter, M. O., & Hayley, S. (2005). Cytokines as a precipitant of depressive illness: Animal and human studies. Current Pharmaceutical Design, 11(8), 963-972.
3. Anisman, H., Ravindran, A. V., Griffiths, J., & Merali, Z. (1999). Interleukin-1 beta production in dysthymia before and after pharmacotherapy. Biological Psychiatry, 46(12), 1649-1655.
4. Bell, C., Abrams, J., & Nutt, D. (2001). Tryptophan depletion and its implications for psychiatry. British Journal of Psychiatry, 178, 399-405.
5. Besedovsky, H., Del Rey, A., Sorkin, E., & Dinarello, C. A. (1986). Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science, 233(4764), 652-654.
6. Bluthe, R. M., Dantzer, R., & Kelley, K. W. (1992). Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat. Brain Research, 573(2), 318-320.
7. Bonaccorso, S., Marino, V., Puzella, A., Pasquini, M., Biondi, M., & Artini, M. (2002). Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. Journal of Clinical Psychopharmacology, 22(1), 86-90.
8. Capuron, L., Gumnick, J. F., Musselman, D. L., Lawson, D. H., Reemsnyder, A., & Nemeroff, C. B. (2002a). Neurobehavioral effects of interferon-alpha in cancer patients: Phenomenology and paroxetine responsiveness of symptom dimensions. Neuropsychopharmacology, 26(5), 643-652.
9. Capuron, L., Raison, C. L., Musselman, D. L., Lawson, D. H., Nemeroff, C. B., & Miller, A. H. (2003). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. American Journal of Psychiatry, 160(7), 1342-1345.
10. Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002b). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry, 7(5), 468-473.
11. Chrousos, G. P. (1995). The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. New England Journal of Medicine, 332(20), 1351-1362.
12. Czeh, B., Michaelis, T., Watanabe, T., Frahm, J., De Biurrun, G., & Van Kampen, M. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proceedings of the National Academy of Science USA, 98(22), 12796-12801.
13. Dunn, A. J. (1992). The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin. Brain Research Bulletin, 29(6), 807-812.
14. Dunn, A. J., Swiergiel, A. H., & De Beaurepaire, R. (2005). Cytokines as mediators of depression: What can we learn from animal studies? Neuroscience & Biobehavioural Reviews, 29(4-5), 891-909.
15. Foley, F. W., Traugott, U., Larocca, N. G., Smith, C. R., Perlman, K. R., & Caruso, L. S. (1992). A prospective study of depression and immune dysregulation in multiple sclerosis. Archives of Neurology, 49(3), 238-244.
16. Frommberger, U. H., Bauer, J., Haselbauer, P., Fraulin, A., Riemann, D., & Berger, M. (1997). Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: Comparison between the acute state and after remission. European Archives in Psychiatry & Clinical Neuroscience, 247(4), 228-233.
17. Goshen, I., Yirmiya, R., Iverfeldt, K., & Weidenfeld, J. (2003). The role of endogenous interleukin-1 in stress-induced adrenal activation and adrenalectomy-induced adrenocorticotropic hormone hypersecretion. Endocrinology, 144(10), 4453-4458.
18. Gould, E., Tanapat, P., McEwen, B. S., Flugge, G., & Fuchs, E. (1998). Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proceedings of the National Academy of Science USA, 95(6), 3168-3171.
19. Hagan, P., Poole, S., & Bristow, A. F. (1993). Endotoxin-stimulated production of rat hypothalamic interleukin-1 beta in vivo and in vitro, measured by specific immunoradiometric assay. Journal of Molecular Endocrinology, 11(1), 31-36.
20. Johnson, J. D., O'Connor, K. A., Deak, T., Stark, M., Watkins, L. R., & Maier, S. F. (2002). Prior stressor exposure sensitizes LPS-induced cytokine production. Brain, Behaviour & Immunity, 16(4), 461-476.
21. Kent, S., Bluthe, R. M., Kelley, K. W., & Dantzer, R. (1992). Sickness behavior as a new target for drug development. Trends in Pharmacological Science, 13(1), 24-28.
22. Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U., & Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22(4), 370-379.
23. Levine, J., Barak, Y., Chengappa, K. N., Rapoport, A., Rebey, M., & Barak, V. (1999). Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology, 40(4), 171-176.
24. Madsen, T. M., Treschow, A., Bengzon, J., Bolwig, T. G., Lindvall, O., & Tingstrom, A. (2000). Increased neurogenesis in a model of electroconvulsive therapy. Biological Psychiatry, 47(12), 1043-1049.
25. Maes, M. (2001). The immunoregulatory effects of antidepressants. Human Psychopharmacology, 16(1), 95-103.
26. Maes, M., Bosmans, E., & Meltzer, H. Y. (1995). Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol. European Archives in Psychiatry & Clinical Neuroscience, 245(3), 172-178.
27. Maes, M., Lin, A. H., Delmeire, L., Van Gastel, A., Kenis, G., & De Jongh, R. (1999). Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in post-traumatic stress disorder following accidental man-made traumatic events. Biological Psychiatry, 45(7), 833-839.
28. Maes, M., Meltzer, H. Y., Scharpe, S., Bosmans, E., Suy, E., & De Meester, I. (1993a). Relationships between lower plasma L-tryptophan levels and immune-inflammatory variables in depression. Psychiatry Research, 49(2), 151-165.
29. Maes, M., Scharpe, S., Meltzer, H. Y., Bosmans, E., Suy, E., & Calabrese, J. (1993b). Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Research, 49(1), 11-27.
30. Maes, M., Song, C., Lin, A., De Jongh, R., Van Gastel, A., & Kenis, G. (1998). The effects of psychological stress on humans: Increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine, 10(4), 313-318.
31. Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000). Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. Journal of Neuroscience, 20(24), 9104-9110.
32. Mohr, D. C., Goodkin, D. E., Islar, J., Hauser, S. L., & Genain, C. P. (2001). Treatment of depression is associated with suppression of nonspecific and antigen-specific T(H)1 responses in multiple sclerosis. Archives in Neurology, 58(7), 1081-1086.
33. Mohr, D. C., Hart, S. L., Julian, L., Cox, D., & Pelletier, D. (2004). Association between stressful life events and exacerbation in multiple sclerosis: A meta-analysis. British Medical Journal, 328(7442), 731.
34. Monje, M. L., Toda, H., & Palmer, T. D. (2003). Inflammatory blockade restores adult hippocampal neurogenesis. Science, 302(5651), 1760-1765.
35. Patten, S. B., & Metz, L. M. (1997). Depression in multiple sclerosis. Psychotherapy & Psychosomatics, 66(6), 286-292.
36. Perlstein, R. S., Whitnall, M. H., Abrams, J. S., Mougey, E. H., & Neta, R. (1993). Synergistic roles of interleukin-6, interleukin-1, and tumor necrosis factor in the adrenocorticotropin response to bacterial lipopolysaccharide in vivo. Endocrinology, 132(3), 946-952.
37. Pollak, Y., Ovadia, H., Goshen, I., Gurevich, R., Monsa, K., & Avitsur, R. (2000). Behavioral aspects of experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 104(1), 31-36.
38. Rabkin, J. G., Albert, S. M., Del Bene, M. L., O'sullivan, I., Tider, T., & Rowland, L. P. (2005). Prevalence of depressive disorders and change over time in late-stage ALS. Neurology, 65(1), 62-67.
39. Ramamoorthy, S., Ramamoorthy, J. D., Prasad, P. D., Bhat, G. K., Mahesh, V. B., & Leibach, F. H. (1995). Regulation of the human serotonin transporter by interleukin-1 beta. Biochemical & Biophysical Research Communications, 216(2), 560-567.
40. Reichenberg, A., Yirmiya, R., Schuld, A., Kraus, T., Haack, M., & Morag, A. (2001). Cytokine-associated emotional and cognitive disturbances in humans. Archives in General Psychiatry, 58(5), 445-452.
41. Sakic, B., Denburg, J. A., Denburg, S. D., & Szechtman, H. (1996). Blunted sensitivity to sucrose in autoimmune MRL-lpr mice: A curve-shift study. Brain Research Bulletin, 41(5), 305-311.
42. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., & Dulawa, S. (2003). Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science, 301(5634), 805-809.
43. Sapolsky, R. M. (2004). Is impaired neurogenesis relevant to the affective symptoms of depression? Biological Psychiatry, 56(3), 137-139.
44. Schiepers, O. J., Wichers, M. C., & Maes, M. (2005). Cytokines and major depression. Progress in Neuropsychopharmacology & Biological Psychiatry, 29(2), 201-217.
45. Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996). Hippocampal atrophy in recurrent major depression. Proceedings of the National Academy of Science USA, 93(9), 3908-3913.
46. Smith, R. S. (1991). The macrophage theory of depression. Medical Hypotheses, 35,298-306.
47. Song, C., Merali, Z., & Anisman, H. (1999). Variations of nucleus accumbens dopamine and serotonin following systemic interleukin-1, interleukin-2 or interleukin-6 treatment. Neuroscience, 88(3), 823-836.
48. Stone, T. W., & Darlington, L. G. (2002). Endogenous kynurenines as targets for drug discovery and development. Nature Reviews. Drug Discovery,1(8), 609-620.
49. Taylor, M. W., & Feng, G. S. (1991). Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. The FASEB journal: official publication of the Federation of American Societies for Experimental Biology, 5(11), 2516-2522.
50. Tilders, F. J., & Schmidt, E. D. (1998). Interleukin-1-induced plasticity of hypothalamic CRH neurons and long-term stress hyper- responsiveness. Annals of the New York Academy of Science, 840,65-73.
51. Vallieres, L., Campbell, I. L., Gage, F. H., & Sawchenko, P. E. (2002). Reduced hippocampal neurogenesis in adult transgenic mice with chronic astrocytic production of interleukin-6. Journal of Neuroscience, 22(2), 486-492.
52. Wichers, M. C., & Maes, M. (2004). The role of indoleamine 2,3-dioxygenase (IDO) in the pathophysiology of interferon-alpha-induced depression. Journal of Psychiatry & Neuroscience, 29(1), 11-17.
53. Young, E. A., Haskett, R. F., Murphy-Weinberg, V., Watson, S. J., & Akil, H. (1991). Loss of glucocorticoid fast feedback in depression. Archives in General Psychiatry, 48(8), 693-699.
54. Zhou, D., Kusnecov, A. W., Shurin, M. R., Depaoli, M., & Rabin, B. S. (1993). Exposure to physical and psychological stressors elevates plasma interleukin 6: Relationship to the activation of hypothalamic-pituitary-adrenal axis. Endocrinology, 133(6), 2523-2530.
55. Zhou, D., Shanks, N., Riechman, S. E., Liang, R., Kusnecov, A. W., & Rabin, B. S. (1996). Interleukin 6 modulates interleukin-1 and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats. Neuroendocrinology, 63(3), 227-236.